Owen Hughes

Insider Reports History

Location
Boston, MA
Signature
/s/ Thomas Burns, Attorney-in-Fact for Owen Hughes
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Owen Hughes:

Company Role Class Num Shares Value Price $ Report Date Ownership
XOMA Royalty Corp Chief Executive Officer, Director Common Stock 98,268 $3,124,922 $31.80 04 Dec 2025 Direct
XOMA Royalty Corp Chief Executive Officer, Director Performance Stock Units 132,714 $3,078,580 $13.89 19 Sep 2025 Direct
XOMA Royalty Corp Chief Executive Officer, Director Depositary Shares - 8.375% B Cumulative Stock 102,000 $2,555,100 $25.05 04 Dec 2025 Direct
XOMA Royalty Corp Chief Executive Officer, Director Common Stock 295 $9,381 $31.80 04 Dec 2025 By 401(k) Plan
C4 Therapeutics, Inc. Director Stock Option (Right to Buy) 35,500 18 Jun 2025 Direct
PARDES BIOSCIENCES, INC. Director Class A Common Stock 30,000 23 Dec 2021 Direct
Ikena Oncology, Inc. Director Stock Option (Right to Buy) 17,520 07 Jun 2024 Direct
XOMA Royalty Corp Chief Executive Officer, Director Depository Shares - 8.375% Series B Cumulative Stock 2,000 19 Sep 2025 Direct
PARDES BIOSCIENCES, INC. Director Class B Common Stock 0 23 Dec 2021 Direct
Radius Health, Inc. Director Common Stock 0 $10.00 15 Aug 2022 Direct
Radius Health, Inc. Director Stock Option (Right to Buy) 0 $4.16 15 Aug 2022 Direct
Translate Bio, Inc. Director Common Stock 0 14 Sep 2021 Direct
Translate Bio, Inc. Director Stock Option (righ to buy) 0 14 Sep 2021 Direct
Translate Bio, Inc. Director Stock Option (right to buy) 0 14 Sep 2021 Direct

Insider Reports Filed by Owen Hughes

Symbol Company Period Transactions Value $ Form Type Role Filing Time
XOMA XOMA Royalty Corp 04 Dec 2025 1 +$2,505,000 4 Chief Executive Officer, Director 08 Dec 2025, 16:30
XOMA XOMA Royalty Corp 19 Sep 2025 2 $0 4 Chief Executive Officer, Director 23 Sep 2025, 17:32
CCCC C4 Therapeutics, Inc. 18 Jun 2025 1 $0 4 Director 20 Jun 2025, 16:11
XOMA XOMA Royalty Corp 19 May 2025 3 -$650,667 4 Chief Executive Officer, Director 21 May 2025, 19:11
XOMA XOMA Royalty Corp 11 Nov 2024 3 -$655,336 4 Chief Executive Officer, Director 13 Nov 2024, 18:55
CCCC C4 Therapeutics, Inc. 20 Jun 2024 1 $0 4 Director 21 Jun 2024, 16:09
IKNA Ikena Oncology, Inc. 07 Jun 2024 1 $0 4 Director 10 Jun 2024, 16:15
XOMA XOMA Corp 08 Jan 2024 1 $0 4 Chief Executive Officer, Director 10 Jan 2024, 16:30
CCCC C4 Therapeutics, Inc. 16 Nov 2023 1 $0 4 Director 20 Nov 2023, 16:21
CCCC C4 Therapeutics, Inc. 16 Nov 2023 0 $0 3 Director 20 Nov 2023, 16:18
XOMA XOMA Corp 02 Oct 2023 1 +$13,830 4 Exec Chairman and Interim CEO, Director 04 Oct 2023, 16:30
XOMA XOMA Corp 25 Sep 2023 2 +$36,075 4 Exec Chairman and Interim CEO, Director 27 Sep 2023, 17:30
IKNA Ikena Oncology, Inc. 09 Jun 2023 1 $0 4 Director 13 Jun 2023, 16:30
XOMA XOMA Corp 23 May 2023 3 +$47,258 4 Interim CEO, Director 25 May 2023, 16:30
XOMA XOMA Corp 03 Jan 2023 2 $0 4 Interim CEO, Director 05 Jan 2023, 15:35
XOMA XOMA Corp 01 Jan 2023 0 $0 3 Interim CEO, Director 06 Jan 2023, 15:30
IKNA Ikena Oncology, Inc. 15 Dec 2022 1 $0 4 Director 19 Dec 2022, 16:21
IKNA Ikena Oncology, Inc. 14 Dec 2022 0 $0 3 Director 19 Dec 2022, 16:11
RDUS Radius Health, Inc. 15 Aug 2022 3 -$318,288 4 Director 15 Aug 2022, 16:19
RDUS Radius Health, Inc. 14 Jan 2022 2 $0 4 Director 25 Jan 2022, 15:30
/report/000121390021068108-hughes-owen-2021-12-23-restatement PARDES BIOSCIENCES, INC. 23 Dec 2021 2 $0 4/A Director 30 Dec 2021, 15:00
/report/000120919121056049-hughes-owen-2021-09-14 Translate Bio, Inc. 14 Sep 2021 5 -$1,134,680 4 Director 14 Sep 2021, 19:26
/report/000120919121040977-hughes-owen-2021-06-16 Translate Bio, Inc. 16 Jun 2021 1 $0 4 Director 16 Jun 2021, 17:14